CHF 550 Million Financing for medmix
medmix AG, in connection with its spin-off from Sulzer AG and its separate listing on SIX Swiss Exchange, entered into a CHF 550 million term loan and revolving credit facilities agreement with a syndicate of banks.
Lenz & Staehelin acted as counsel to the lenders.